UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by HB Wealth Management LLC

HB Wealth Management LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% during the fourth quarter, Holdings Channel reports. The firm owned 51,986 shares of the healthcare conglomerate’s stock after purchasing an additional 1,029 shares during the period. HB Wealth Management LLC’s holdings in UnitedHealth Group were worth $26,298,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Pacer Advisors Inc. increased its holdings in shares of UnitedHealth Group by 5.7% in the 2nd quarter. Pacer Advisors Inc. now owns 65,860 shares of the healthcare conglomerate’s stock valued at $33,540,000 after acquiring an additional 3,525 shares during the period. Garden State Investment Advisory Services LLC increased its stake in UnitedHealth Group by 13.5% in the second quarter. Garden State Investment Advisory Services LLC now owns 1,049 shares of the healthcare conglomerate’s stock valued at $536,000 after purchasing an additional 125 shares during the period. Columbus Hill Capital Management L.P. acquired a new stake in shares of UnitedHealth Group during the second quarter worth about $14,789,000. Summit Trail Advisors LLC increased its position in UnitedHealth Group by 33.3% in the 2nd quarter. Summit Trail Advisors LLC now owns 12,008 shares of the healthcare conglomerate’s stock valued at $6,115,000 after acquiring an additional 2,999 shares during the period. Finally, Transatlantique Private Wealth LLC grew its stake in shares of UnitedHealth Group by 9.9% in the 2nd quarter. Transatlantique Private Wealth LLC now owns 2,594 shares of the healthcare conglomerate’s stock valued at $1,291,000 after purchasing an additional 234 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $510.03 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market capitalization of $469.37 billion, a price-to-earnings ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a fifty day moving average of $549.37 and a two-hundred day moving average of $562.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the company earned $5.83 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.65%. UnitedHealth Group’s payout ratio is currently 54.72%.

Analysts Set New Price Targets

A number of research firms recently weighed in on UNH. Piper Sandler lowered their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. KeyCorp reissued an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a report on Friday. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Finally, Stephens raised their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Two analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.